Here, we characterize this novel FoxO3A function in cancer cells and provide compelling molecular evidence that in metabolically stressed cancer cells and tumors FoxO3A is recruited to the mitochondrial surface in a MEK/ERK- and AMPK-dependent manner, while only the MEK/ERK signal is required in cancer cells treated with chemotherapeutic agents. The gene discussed is FOXO3; the disease is cancer.